Epalex

Palo Alto, United States

Epalex is developing a novel inhaled treatment for epilepsy and migraine.

$1.2M raised

Nov 2025

Venture - Series Unknown

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Epalex

How much funding has Epalex raised?

Epalex has raised $1.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.

Where is Epalex headquartered?

Epalex is headquartered in Palo Alto, United States.

What does Epalex do?

Epalex is developing a novel inhaled treatment for epilepsy and migraine.

What stage is Epalex at?

Epalex is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 9, 2025.

MLA

"Epalex — Funding & Investors." VCBacked, November 9, 2025, https://www.vcbacked.co/company/epalex. Accessed July 3, 2026.

APA

VCBacked. (2025). Epalex — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/epalex

Wikipedia (cite web)

{{cite web |title=Epalex — Funding & Investors |url=https://www.vcbacked.co/company/epalex |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 9, 2025.